[en] BACKGROUND: A complete understanding of the different steps of HIV replication and an effective drug combination have led to modern antiretroviral regimens that block HIV replication for decades, but these therapies are not curative and must be taken for life. "Elite controllers" (ECs) is a term for the 0.5% of HIV-infected persons requiring no antiretroviral therapy, whose status may point the way toward a functional HIV cure. Defining the mechanisms of this control may be key to understanding how to replicate this functional cure in others.
METHODS: In ECs and untreated non-EC patients, we compared IFNα serum concentration, distribution of immune cell subsets, and frequency of cell markers associated with immune dysfunction. We also investigated the effect of an elevated dose of IFNα on distinct subsets within dendritic cells, natural killer cells, and CD4+ and CD8 + T cells.
RESULTS: Serum IFNα was undetectable in ECs, but all immune cell subsets from untreated non-EC patients were structurally and functionally impaired. We also show that the altered phenotype and function of these cell subsets in non-EC patients can be recapitulated when cells are stimulated in vitro with high-dose IFNα.
CONCLUSIONS: Elevated IFNα is a key mediator of HIV pathogenesis.
Disciplines :
Immunology & infectious disease
Author, co-author :
Buanec, Hélène Le; Université de Paris, INSERM U976, HIPI Unit, Institut de Recherche Saint-Louis, F-75010, Paris, France
Schiavon, Valérie; Université de Paris, INSERM U976, HIPI Unit, Institut de Recherche Saint-Louis, F-75010, Paris, France
Merandet, Marine; Université de Paris, INSERM U976, HIPI Unit, Institut de Recherche Saint-Louis, F-75010, Paris, France
How-Kit, Alexandre; Laboratory for Genomics Foundation Jean Dausset-CEPH, Paris, France
Bergerat, David ; Université de Paris, INSERM U976, HIPI Unit, Institut de Recherche Saint-Louis, F-75010, Paris, France
Bensussan, Armand ; Université de Paris, INSERM U976, HIPI Unit, Institut de Recherche Saint-Louis, F-75010, Paris, France
Bouaziz, Jean-David; Université de Paris, INSERM U976, HIPI Unit, Institut de Recherche Saint-Louis, F-75010, Paris, France ; Dermatology Department, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
Burny, Arsène ; Université de Liège - ULiège ; Global Virus Network, Baltimore, MD, 21201, USA
Darcis, Gilles ; Université de Liège - ULiège > Département des sciences cliniques
Song, Hongshuo; Institute of Human Virology, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA
Sajadi, Mohammad M; Global Virus Network, Baltimore, MD, 21201, USA ; Institute of Human Virology, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA ; University of Maryland School of Medicine, Baltimore, MD, 21201, USA
Kottilil, Shyamasundaran; Global Virus Network, Baltimore, MD, 21201, USA ; Institute of Human Virology, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA ; University of Maryland School of Medicine, Baltimore, MD, 21201, USA
Gallo, Robert C ; Global Virus Network, Baltimore, MD, 21201, USA. rgallo@ihv.umaryland.edu ; Institute of Human Virology, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA. rgallo@ihv.umaryland.edu
S.G. Deeks B.D. Walker Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy Immunity 2007 27 406 416 1:CAS:528:DC%2BD2sXhtFWmu7bL 10.1016/j.immuni.2007.08.010 17892849
C. Jiang et al. Distinct viral reservoirs in individuals with spontaneous control of HIV-1 Nature 2020 585 261 267 2020Natur.585.261J 1:CAS:528:DC%2BB3cXhs12jt7nF 10.1038/s41586-020-2651-8 32848246 7837306
M.P. Martin et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1 Nat. Genet. 2007 39 733 740 1:CAS:528:DC%2BD2sXlvVSgt70%3D 10.1038/ng2035 17496894 4135476
S.A. Migueles et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors Proc. Natl Acad. Sci. USA 2000 97 2709 2714 2000PNAS..97.2709M 1:CAS:528:DC%2BD3cXitVahs70%3D 10.1073/pnas.050567397 10694578 15994
D. Zagury et al. Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS Proc. Natl Acad. Sci. USA 1998 95 3851 3856 1998PNAS..95.3851Z 1:CAS:528:DyaK1cXitlKjtbo%3D 10.1073/pnas.95.7.3851 9520456 19926
A. Gringeri et al. A randomized, placebo-controlled, blind anti-AIDS clinical trial: safety and immunogenicity of a specific anti-IFN alpha immunization J. Acquir. Immune Defic. Syndr. 1994 7 978 988 1:STN:280:DyaK2czivVagsA%3D%3D 7914235
L. Cha E. de Jong M.A. French S. Fernandez IFN-α exerts opposing effects on activation-induced and IL-7–induced proliferation of T cells that may impair homeostatic maintenance of CD4 + T cell numbers in treated HIV infection J. Immunol. 2014 193 2178 2186 1:CAS:528:DC%2BC2cXhtlOnurjM 10.4049/jimmunol.1302536 25063872
E. Dondi L. Rogge G. Lutfalla G. Uzé S. Pellegrini Down-modulation of responses to type I IFN upon T cell activation J. Immunol. 2003 170 749 756 1:CAS:528:DC%2BD3sXktlGgug%3D%3D 10.4049/jimmunol.170.2.749 12517937
M. Aman et al. Interferon-alpha stimulates production of interleukin-10 in activated CD4+ T cells and monocytes Blood 1996 87 4731 4736 1:CAS:528:DyaK28Xjt1Cjsr4%3D 10.1182/blood.V87.11.4731.bloodjournal87114731 8639843
H. Le Buanec et al. IFN- and CD46 stimulation are associated with active lupus and skew natural T regulatory cell differentiation to type 1 regulatory T (Tr1) cells Proc. Natl Acad. Sci. USA 2011 108 18995 19000 2011PNAS.10818995L 10.1073/pnas.1113301108 22065791 3223453
R.L. Friedman S.P. Manly M. McMahon I.M. Kerr G.R. Stark Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells Cell 1984 38 745 755 1:CAS:528:DyaL2cXmt1ygsLc%3D 10.1016/0092-8674(84)90270-8 6548414
H.M. Lazear J.W. Schoggins M.S. Diamond Shared and distinct functions of type I and type III interferons Immunity 2019 50 907 923 1:CAS:528:DC%2BC1MXnsFGks7s%3D 10.1016/j.immuni.2019.03.025 30995506 6839410
G. Reis et al. Early treatment with pegylated interferon lambda for Covid-19 N. Engl. J. Med. 2023 388 518 528 1:CAS:528:DC%2BB3sXjtlent7k%3D 10.1056/NEJMoa2209760 36780676 9933926
Le Buanec, H. et al. Early elevated IFNα is a key mediator of HIV pathogenesis. Comms Med. https://doi.org/10.1038/s43856-024-00454-6 (2024).
Jacquelin, B. et al. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J. Clin. Invest. https://doi.org/10.1172/JCI40093 (2009).
L.D. Harris et al. Downregulation of robust acute type I interferon responses distinguishes nonpathogenic Simian immunodeficiency virus (SIV) infection of natural hosts from pathogenic SIV infection of rhesus macaques J. Virol. 2010 84 7886 7891 1:CAS:528:DC%2BC3cXhtVejt73I 10.1128/JVI.02612-09 20484518 2897601
A. Gringeri et al. Active anti-interferon-alpha immunization: a European-Israeli, randomized, double-blind, placebo-controlled clinical trial in 242 HIV-1–infected patients (the EURIS study) J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1999 20 358 370 1:CAS:528:DyaK1MXit1ahs74%3D 10.1097/00042560-199904010-00006 10096580
Le Buanec, H. et al. IFNa-induces CCR5 in CD4+ T cells of HIV patients causing pathogenic elevation. Commun Med. https://doi.org/10.1038/s43856-024-00453-7 (2024).
V. Schiavon et al. Microenvironment tailors nTreg structure and function Proc. Natl Acad. Sci. USA 2019 116 6298 6307 2019PNAS.116.6298S 1:CAS:528:DC%2BC1MXlvFenurc%3D 10.1073/pnas.1812471116 30846549 6442590
H. Lecoeur L.M. de Oliveira-Pinto M.-L. Gougeon Multiparametric flow cytometric analysis of biochemical and functional events associated with apoptosis and oncosis using the 7-aminoactinomycin D assay J. Immunol. Methods 2002 265 81 96 1:CAS:528:DC%2BD38XksFKgtbo%3D 10.1016/S0022-1759(02)00072-8 12072180
R.M. Van der Sluis et al. Diverse effects of interferon alpha on the establishment and reversal of HIV latency PLoS Pathog. 2020 16 e1008151 10.1371/journal.ppat.1008151 32109259 7065813
J. Du et al. Persistent high percentage of HLA-DR+CD38high CD8+ T cells associated with immune disorder and disease severity of COVID-19 Front. Immunol. 2021 12 735125 1:CAS:528:DC%2BB3MXisVakt7zL 10.3389/fimmu.2021.735125 34567001 8458852
Y. Huang et al. Inhibition of the adenosinergic pathway: the indispensable part of oncological therapy in the future Purinergic Signal. 2019 15 53 67 1:CAS:528:DC%2BC1MXmtlyntLc%3D 10.1007/s11302-018-9641-4 30809739 6439062
H. Jiang L. Chess The specific regulation of immune responses by CD8+ T cells restricted by the MHC class Ib molecule, Qa-1 Annu. Rev. Immunol. 2000 18 185 216 1:CAS:528:DC%2BD3cXjs1Gmsb4%3D 10.1146/annurev.immunol.18.1.185 10837057
K.A. Marijt E.M. Doorduijn T. van Hall TEIPP antigens for T cell based immunotherapy of immune-edited HLA class Ilow cancers Mol. Immunol. 2019 113 43 49 1:CAS:528:DC%2BC1cXntVGhs7g%3D 10.1016/j.molimm.2018.03.029 29627136
S.A. Joosten L.C. Sullivan T.H.M. Ottenhoff Characteristics of HLA-E restricted T cell responses and their role in infectious Dis. J. Immunol. Res. 2016 2016 1 11 10.1155/2016/2695396
A. Poli et al. CD56 bright natural killer (NK) cells: an important NK cell subset Immunology 2009 126 458 465 1:CAS:528:DC%2BD1MXjslSnsbw%3D 10.1111/j.1365-2567.2008.03027.x 19278419 2673358
G. Alter et al. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection Blood 2005 106 3366 3369 1:CAS:528:DC%2BD2MXht1ehsb7K 10.1182/blood-2005-03-1100 16002429
V. Soumelis et al. Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients Blood 2001 98 906 912 1:CAS:528:DC%2BD3MXmtFeisrg%3D 10.1182/blood.V98.4.906 11493432
B. Schmidt B.M. Ashlock H. Foster S.H. Fujimura J.A. Levy HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration Virology 2005 343 256 266 1:CAS:528:DC%2BD2MXht1aqt7%2FM 10.1016/j.virol.2005.09.059 16278001
L. Cheng et al. Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs J. Clin. Invest. 2016 127 269 279 10.1172/JCI90745 27941247 5199717
F. Sallusto D. Lenig R. Förster M. Lipp A. Lanzavecchia Two subsets of memory T lymphocytes with distinct homing potentials and effector functions Nature 1999 401 708 712 1999Natur.401.708S 1:CAS:528:DyaK1MXntVWntrw%3D 10.1038/44385 10537110
A.R. Stacey et al. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections J. Virol. 2009 83 3719 3733 1:CAS:528:DC%2BD1MXktlSju7k%3D 10.1128/JVI.01844-08 19176632 2663284
O. Schwartz V. Maréchal S. Le Gall F. Lemonnier J.M. Heard Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein Nat. Med. 1996 2 338 342 1:CAS:528:DyaK28XhsVGkt7Y%3D 10.1038/nm0396-338 8612235
F. Sallusto J. Geginat A. Lanzavecchia Central memory and effector memory T cell subsets: function, generation, and maintenance Annu. Rev. Immunol. 2004 22 745 763 1:CAS:528:DC%2BD2cXktlOgsb8%3D 10.1146/annurev.immunol.22.012703.104702 15032595
H.-J. Kim et al. CD8 + T regulatory cells express the Ly49 Class I MHC receptor and are defective in autoimmune prone B6-Yaa mice Proc. Natl Acad. Sci. USA 2011 108 2010 2015 2011PNAS.108.2010K 1:CAS:528:DC%2BC3MXhslyjtrg%3D 10.1073/pnas.1018974108 21233417 3033298
J. Li et al. KIR+CD8+ T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19 Science 2022 376 eabi9591 1:CAS:528:DC%2BB38XhtFSgsLbK 10.1126/science.abi9591 35258337 8995031
J. Dutrieux et al. Modified interferon-α subtypes production and chemokine networks in the thymus during acute simian immunodeficiency virus infection, impact on thymopoiesis AIDS 2014 28 1101 1113 1:CAS:528:DC%2BC2cXhtVOgt7zJ 10.1097/QAD.0000000000000249 24614087
M. Altfeld P. Goulder ‘Unleashed’ natural killers hinder HIV Nat. Genet. 2007 39 708 710 1:CAS:528:DC%2BD2sXlvVSgtrk%3D 10.1038/ng0607-708 17534364
Le Buanec, H. et al. Early elevated IFNα is a key mediator of HIV pathogenesis. Comms Med. https://doi.org/10.6084/m9.figshare.25125377 (2024).
